Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

An explorative literature review of the multifactorial causes of osteoporosis in epilepsy

Research output: Contribution to journalReviewResearchpeer-review

  1. Why are antiepileptic drugs continued after successful epilepsy surgery in adults?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Psychogenic nonepileptic seizures treated with psychotherapy: Long-term outcome on seizures and healthcare utilization

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Welfare consequences for people diagnosed with nonepileptic seizures: A matched nationwide study in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Morbidity and mortality of nonepileptic seizures (NES): A controlled national study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Decreased markers of bone turnover in children and adolescents with type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: Patients with epilepsy have a greatly increased risk of osteoporosis and fractures. The literature is diverse and contradictory when dealing with the underlying pathophysiological mechanisms. Consequently, the purpose of this review was to shed light on the multifactorial causes behind the increased occurrence of metabolic bone disease in patients with epilepsy and to identify areas for future research.

METHODS: A review of the literature was performed searching PubMed with relevant Medical Subject Headings MeSH terms. The results of the search were evaluated for relevance to the review based on the title and abstract of the publication. Publications in language other than English and publications pertaining only pediatric patients were excluded. For all studies, included reference lists were evaluated for further relevant publications. In total, 96 publications were included in this explorative review.

RESULTS: The high occurrence of metabolic bone disease in patients with epilepsy is multifactorial. The causes are the socioeconomic consequences of having a chronic neurological disease but also adverse effects to antiepileptic drug treatment ranging from interference with calcium and vitamin D metabolism to hyponatremia-induced osteoporosis.

CONCLUSION: The literature supports the need for awareness of bone health in patients with epilepsy. The pathophysiological mechanisms are many and various wanting for further research in the less well-characterized areas. Furthermore, great responsibility rests on the healthcare professionals in implementing comprehensive patient care and in assuring bone protective measures in clinical practice to prevent bone loss in patients with epilepsy.

Original languageEnglish
JournalEpilepsy and Behavior
Volume100
Issue numberPt A
Pages (from-to)106511
ISSN1525-5050
DOIs
Publication statusPublished - 2019

ID: 57969323